Table 2.
Hip fracture | Upper limb fracture | CVD | ESRD | |||||
---|---|---|---|---|---|---|---|---|
(−) | (+) | (−) | (+) | (−) | (+) | (−) | (+) | |
Unadjusted | 1.00 (Ref.) | 3.48 (2.06–5.61) | 1.00 (Ref.) | 0.71 (0.49–0.99) | 1.00 (Ref.) | 2.78 (2.20–3.51) | 1.00 (Ref.) | 3.49 (2.04–5.70) |
Age‐ and sex‐adjusted | 1.00 (Ref.) | 2.99 (1.75–4.89) | 1.00 (Ref.) | 0.79 (0.55–1.11) | 1.00 (Ref.) | 2.03 (1.59–2.58) | 1.00 (Ref.) | 3.31 (1.89–5.52) |
Multivariate‐adjusted | 1.00 (Ref.) | 2.67 (1.54–4.41) | 1.00 (Ref.) | 0.77 (0.53–1.10) | 1.00 (Ref.) | 1.78 (1.39–2.27) | 1.00 (Ref.) | 2.36 (1.32–4.05) |
Multivariate‐adjusted + CVD + ESRD | 1.00 (Ref.) | 2.74 (1.58–4.54) |
Multivariate‐adjusted model: age, sex, duration of diabetes, body mass index, current smoking habits, current drinking habits, leisure‐time physical activity, hemoglobin A1c, systolic blood pressure, low‐density lipoprotein cholesterol, and insulin therapy. CVD, cardiovascular disease; ESRD, end‐stage renal disease.